The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity
Open accessAbstract
Constitutive nuclear nuclear factor (NF)-κB activity is observed in a variety of hematopoietic and solid tumors. Given the distinctive role of constitutive NF-κB for Hodgkin and Reed-Sternberg (HRS) cell viability, we performed molecular profiling in two Hodgkin's disease (HD) cell lines to identify NF-κB target genes. We recognized 45 genes whose expression in both cell lines was regulated by NF-κB. The NF-κB–dependent gene profile comprises chemokines, cytokines, receptors, apoptotic regulators, intracellular signaling molecules, and transcription factors, the majority of which maintain a marker-like expression in HRS cells. Remarkably, we found 17 novel NF-κB target genes. Using chromatin immunoprecipitation we demonstrate that NF-κB is recruited directly to the promoters of several target genes, including signal transducer and activator of transcription (STAT)5a, interleukin-13, and CC chemokine receptor 7. Intriguingly, NF-κB positively regulates STAT5a expression and signaling pathways in HRS cells, and promotes its persistent activation. In fact, STAT5a overexpression was found in most tumor cells of tested patients with classical HD, indicating a critical role for HD. The gene profile underscores a central role of NF-κB in the pathogenesis of HD and potentially of other tumors with constitutive NF-κB activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Oncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
The inducible transcription activator NF-κB: regulation by distinct protein subunits
Baeuerle, P. A. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90007-8 · Cited by 1,031
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Self-citationStein, B., Baldwin, A. S., Ballard, D. W., Greene, W. C., Angel, P., & Herrlich, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06066.x · Cited by 629
The nature and action of granulocyte-macrophage colony stimulating factors
Burgess, A., & Metcalf, D. (1980) · Blood · doi:10.1182/blood.v56.6.947.947 · Cited by 559
Stat5 Is Required for IL-2-Induced Cell Cycle Progression of Peripheral T Cells
Moriggl, R., Topham, D. J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M. Y., Bunting, K. D., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80025-4 · Cited by 547
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen, Z., Malhotra, P. S., Thomas, G. R., Ondrey, F. G., Duffey, D. C., Smith, C. W., Enamorado, I. I., Yeh, N. T., Kroog, G. S., Rudy, S., et al. (1999) · PubMed · Cited by 486
New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation
Chen, F., Castranova, V., & Shi, X. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61708-7 · Cited by 473
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed · Cited by 461
Significance of CD44 gene products for cancer diagnosis and disease evaluation
Matsumura, Y., & Tarin, D. (1992) · The Lancet · doi:10.1016/0140-6736(92)93077-z · Cited by 450
McLeod, H., Krynetski, E., Relling, M., & Evans, W. (2000) · Leukemia · doi:10.1038/sj.leu.2401723 · Cited by 437
Ardeshna, K. M., Pizzey, A. R., Devereux, S., & Khwaja, A. (2000) · Blood · doi:10.1182/blood.v96.3.1039 · Cited by 430
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 421
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
Two Waves of Nuclear Factor κb Recruitment to Target Promoters
Saccani, S., Pantano, S., & Natoli, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1351 · Cited by 389
HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway
Zhou, B. P., Hu, M. C.-T., Miller, S. A., Yu, Z., Xia, W., Lin, S.-Y., & Hung, M.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8027 · Cited by 371
Horita, M., Andreu, E. J., Benito, A., Arbona, C., Sanz, C., Benet, I., Prosper, F., & Fernandez-Luna, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.977 · Cited by 366
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F., & Hay, R. T. (1999) · Oncogene · doi:10.1038/sj.onc.1202893 · Cited by 334
Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T., & Grumont, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203236 · Cited by 329
High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells
Bargou, R., Leng, C., Krappmann, D., Emmerich, F., Mapara, M., Bommert, K., Royer, H., Scheidereit, C., & Dorken, B. (1996) · Blood · doi:10.1182/blood.v87.10.4340.bloodjournal87104340 · Cited by 309
Self-citationClonal Deleterious Mutations in the Iκbα Gene in the Malignant Cells in Hodgkin's Lymphoma
Jungnickel, B., Staratschek-Jox, A., Bräuninger, A., Spieker, T., Wolf, J., Diehl, V., Hansmann, M.-L., Rajewsky, K., & Küppers, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.395 · Cited by 283
Interleukin 13 Is Secreted by and Stimulates the Growth of Hodgkin and Reed-Sternberg Cells
Kapp, U., Yeh, W.-C., Patterson, B., Elia, A. J., Kägi, D., Ho, A., Hessel, A., Tipsword, M., Williams, A., Mirtsos, C., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1939 · Cited by 276
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dörken, B., & Scheidereit, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202351 · Cited by 271
Self-citationHinz, M., Löser, P., Mathas, S., Krappmann, D., Dörken, B., & Scheidereit, C. (2001) · Blood · doi:10.1182/blood.v97.9.2798 · Cited by 261
Self-citationEmmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.-D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3129 · Cited by 261
Self-citationRel/NF-κB transcription factors and the control of apoptosis
Sonenshein, G. E. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0062 · Cited by 238
Expression of the fructose transporter GLUT5 in human breast cancer.
Zamora-León, S. P., Golde, D. W., Concha, I. I., Rivas, C. I., Delgado-López, F., Baselga, J., Nualart, F., & Vera, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1847 · Cited by 212
STAT signaling in the pathogenesis and treatment of leukemias
Lin, T. S., Mahajan, S., & Frank, D. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203486 · Cited by 205
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
Skinnider, B. F. (2001) · Blood · doi:10.1182/blood.v97.1.250 · Cited by 197
Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation
Kieslinger, M., Woldman, I., Moriggl, R., Hofmann, J., Marine, J.-C., Ihle, J. N., Beug, H., & Decker, T. (2000) · Genes & Development · doi:10.1101/gad.14.2.232 · Cited by 185
Sun, S.-C., & Ballard, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1203220 · Cited by 185
Garcia, G. E., Xia, Y., Chen, S., Wang, Y., Ye, R. D., Harrison, J. K., Bacon, K. B., Zerwes, H.-G., & Feng, L. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.577 · Cited by 179
McFarland, E. D. C., Izumi, K. M., & Mosialos, G. (1999) · Oncogene · doi:10.1038/sj.onc.1203217 · Cited by 159
Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell Transition
Li, J., Peet, G. W., Balzarano, D., Li, X., Massa, P. T., Barton, R. W., & Marcu, K. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100846200 · Cited by 156
Jundt, F., Anagnostopoulos, I., Bommert, K., Emmerich, F., Müller, G., Foss, H., Royer, H., Stein, H., & Dörken, B. (1999) · Blood · doi:10.1182/blood.v94.6.2065 · Cited by 153
Self-citationKanzler, H., Hansmann, M.-L., Kapp, U., Wolf, J., Diehl, V., Rajewsky, K., & Küppers, R. (1996) · Blood · doi:10.1182/blood.v87.8.3429.bloodjournal8783429 · Cited by 151
Tinhofer, I., Marschitz, I., Henn, T., Egle, A., & Greil, R. (2000) · Blood · doi:10.1182/blood.v95.2.610 · Cited by 131
Hasegawa, H., Nomura, T., Kohno, M., Tateishi, N., Suzuki, Y., Maeda, N., Fujisawa, R., Yoshie, O., & Fujita, S. (2000) · Blood · doi:10.1182/blood.v95.1.30 · Cited by 127
Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice
Levy, D. E., & Gilliland, D. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203480 · Cited by 122
Höpken, U. E., Foss, H., Meyer, D., Hinz, M., Leder, K., Stein, H., & Lipp, M. (2002) · Blood · doi:10.1182/blood.v99.4.1109 · Cited by 120
Self-citationThe Molecular and Cellular Origins of Hodgkin's Disease
Staudt, L. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.207 · Cited by 117
Human T Cell Lymphotropic Virus Type I Tax Activates IL-15Rα Gene Expression Through an NF-κB Site
Mariner, J. M., Lantz, V., Waldmann, T. A., & Azimi, N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2602 · Cited by 111
Scholler, N., Hayden-Ledbetter, M. S., Hellström, K.-E., Hellström, I., & Ledbetter, J. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3865 · Cited by 109
Zapata, J. M., Krajewska, M., Krajewski, S., Huang, R., Takayama, S.-I. J., Wang, H., Adamson, E. D., & Reed, J. C. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005940832123 · Cited by 108
Stat5 and Sp1 Regulate Transcription of the Cyclin D2 Gene in Response to IL-2
Martino, A., Holmes, J. H., Lord, J. D., Moon, J. J., & Nelson, B. H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1723 · Cited by 106
Kanazawa, N., Nakamura, T., Tashiro, K., Muramatsu, M., Morita, K., Yoneda, K., Inaba, K., Imamura, S., & Honjo, T. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06<1925::aid-immu1925>3.0.co;2-u · Cited by 102
Interaction between host T cells and Reed–Sternberg cells in Hodgkin lymphomas
Poppema, S., & van den Berg, A. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0327 · Cited by 101
Dürkop, H., Foss, H., Demel, G., Klotzbach, H., Hahn, C., & Stein, H. (1999) · Blood · doi:10.1182/blood.v93.2.617 · Cited by 80
Self-citationHodgkin’s cells express CD83, a dendritic cell lineage associated antigen
Sorg, U. R., Morse, T. M., Patton, W. N., Hock, B. D., Angus, H. B., Robinson, B. A., Colls, B. M., & Hart, D. N. J. (1997) · Pathology · doi:10.1080/00313029700169125 · Cited by 57
The Role of Adhesion Molecules in Multiple Myeloma
Cook, G., Dumbar, M., & FRANKLIN, I. M. (2009) · Acta Haematologica · doi:10.1159/000203663 · Cited by 53
Biology and treatment of multiple myeloma
Niesvizky, R., Siegel, D. S. D., & Michaeli, J. (1993) · Blood Reviews · doi:10.1016/0268-960x(93)90021-u · Cited by 51
Expression of a novel Bcl-2 related gene, Bfl-1, in various human cancers and cancer cell lines.
Park, I. C., Lee, S.-H., Whang, D. Y., Hong, W.-S., Choi, S. S., Shin, H., Choe, T., & Hong, S.-I. (1997) · PubMed · Cited by 37
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
The biology of Hodgkin's lymphoma
Küppers, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2542 · Cited by 688
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Basílio, J., Petzelbauer, P., Assinger, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00085 · Cited by 596
Transcriptional profiling identifies Id2 function in dendritic cell development
Hacker, C., Kirsch, R. D., Ju, X.-S., Hieronymus, T., Gust, T. C., Kuhl, C., Jorgas, T., Kurz, S. M., Rose-John, S., Yokota, Y., et al. (2003) · Nature Immunology · doi:10.1038/ni903 · Cited by 544
Self-citation
Metadata
- Authors
- Hinz, M., Lemke, P., Anagnostopoulos, I., Hacker, C., Krappmann, D., Mathas, S., Dörken, B., Zenke, M., Stein, H., & Scheidereit, C.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-08-26
- Volume
- 196
- Issue
- 5
- Pages
- 605-617
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2126214983
- Cited by
- 266
- References
- 66
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.